Biologic Drugs With Established Pharmaceutical Class: CD22-directed Immunoconjugate
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: CD22-directed Immunoconjugate
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Pharmaceuticals Inc. | BESPONSA | inotuzumab ozogamicin | For Injection | 761040 | 2017-08-17 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |